D
Daniel C. Chung
Researcher at Harvard University
Publications - 307
Citations - 27050
Daniel C. Chung is an academic researcher from Harvard University. The author has contributed to research in topics: Colorectal cancer & Cancer. The author has an hindex of 69, co-authored 290 publications receiving 24211 citations. Previous affiliations of Daniel C. Chung include University of Pennsylvania & Google.
Papers
More filters
Journal ArticleDOI
An Enzyte'ing' case of acute hepatitis.
Vivek S. Ramanathan,Eleni Mitropoulos,Boris Shlopov,Viktor E. Eysselein,Daniel C. Chung,Sonya Reicher,Binh V. Pham +6 more
TL;DR: The first reported case of biopsy proven hepatotoxicity associated with the natural male enhancement supplement, Enzyte is described, with the patient's symptoms and liver function tests resolved with cessation of the popular "mail order" drug.
Journal Article
Mobility testing validation study - Using a novel, standardized mobility test to evaluate functional vision in patients with inherited retinal degeneration
Sarah McCague,Jennifer Wellman,Fan-Fan Yu,Satha Thill,Julie DiStefano-Pappas,Jean Bennett,Dominique Cross,Kathleen A. Marshall,Katherine A. High,Daniel C. Chung +9 more
Journal ArticleDOI
Concordance of EUS and MRI/MRCP findings among high-risk individuals undergoing pancreatic cancer screening.
Ava Siegel,Madeline Friedman,Dan Feldman,Kumar Krishnan,Brenna Casey,Nisanard Pisuchpen,Avinash Kambadakone,Daniel C. Chung +7 more
TL;DR: Worrisome pancreatic lesions were uncommon in the high-risk pancreatic cancer population and were detected by both EUS and MRI/MRCP and were not associated with any adverse clinical outcomes.
Journal ArticleDOI
Concordance of EUS and MRI/MRCP findings among high-risk individuals undergoing pancreatic cancer screening
TL;DR: In this paper , the authors characterize the findings of these surveillance exams and define the level of concordance between these two modalities, including endoscopic ultrasonography (EUS) and MRI/magnetic retrograde cholangiopancreatography (MRCP) for individuals at high risk for pancreatic cancer.
Journal ArticleDOI
Clinical features and long-term outcomes of patients with colonic oligopolyposis of unknown etiology
TL;DR: In this paper , a case series of patients with aden-omatous oligopolyposis (CPUE) and negative genetic testing was identified through the Hereditary Gastrointestinal Cancer Database at Massachusetts General Hospital, a tertiary academic referral center.